Global Measles Attenuated Live Vaccine Supply, Demand and Key Producers, 2023-2029
The global Measles Attenuated Live Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Measles Attenuated Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Measles Attenuated Live Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Measles Attenuated Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Measles Attenuated Live Vaccine total production and demand, 2018-2029, (K Units)
Global Measles Attenuated Live Vaccine total production value, 2018-2029, (USD Million)
Global Measles Attenuated Live Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Measles Attenuated Live Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Measles Attenuated Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Measles Attenuated Live Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Measles Attenuated Live Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Measles Attenuated Live Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Measles Attenuated Live Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, Novartis, Bavarian Nordic, Medimmune and Changchun Keygen Biological Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Measles Attenuated Live Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Measles Attenuated Live Vaccine Market, By Region:
1. How big is the global Measles Attenuated Live Vaccine market?
2. What is the demand of the global Measles Attenuated Live Vaccine market?
3. What is the year over year growth of the global Measles Attenuated Live Vaccine market?
4. What is the production and production value of the global Measles Attenuated Live Vaccine market?
5. Who are the key producers in the global Measles Attenuated Live Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global Measles Attenuated Live Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Measles Attenuated Live Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Measles Attenuated Live Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Measles Attenuated Live Vaccine total production and demand, 2018-2029, (K Units)
Global Measles Attenuated Live Vaccine total production value, 2018-2029, (USD Million)
Global Measles Attenuated Live Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Measles Attenuated Live Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Measles Attenuated Live Vaccine domestic production, consumption, key domestic manufacturers and share
Global Measles Attenuated Live Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Measles Attenuated Live Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Measles Attenuated Live Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Measles Attenuated Live Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, Novartis, Bavarian Nordic, Medimmune and Changchun Keygen Biological Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Measles Attenuated Live Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Measles Attenuated Live Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Powder
- Liquid
- Hospital
- Clinic
- Merck
- Pfizer
- Serum Institute of India
- GSK
- Sanofi-Pasteur
- Novartis
- Bavarian Nordic
- Medimmune
- Changchun Keygen Biological Products
- Shanghai Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
1. How big is the global Measles Attenuated Live Vaccine market?
2. What is the demand of the global Measles Attenuated Live Vaccine market?
3. What is the year over year growth of the global Measles Attenuated Live Vaccine market?
4. What is the production and production value of the global Measles Attenuated Live Vaccine market?
5. Who are the key producers in the global Measles Attenuated Live Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Measles Attenuated Live Vaccine Introduction
1.2 World Measles Attenuated Live Vaccine Supply & Forecast
1.2.1 World Measles Attenuated Live Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Measles Attenuated Live Vaccine Production (2018-2029)
1.2.3 World Measles Attenuated Live Vaccine Pricing Trends (2018-2029)
1.3 World Measles Attenuated Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Measles Attenuated Live Vaccine Production Value by Region (2018-2029)
1.3.2 World Measles Attenuated Live Vaccine Production by Region (2018-2029)
1.3.3 World Measles Attenuated Live Vaccine Average Price by Region (2018-2029)
1.3.4 North America Measles Attenuated Live Vaccine Production (2018-2029)
1.3.5 Europe Measles Attenuated Live Vaccine Production (2018-2029)
1.3.6 China Measles Attenuated Live Vaccine Production (2018-2029)
1.3.7 Japan Measles Attenuated Live Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Measles Attenuated Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Measles Attenuated Live Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Measles Attenuated Live Vaccine Demand (2018-2029)
2.2 World Measles Attenuated Live Vaccine Consumption by Region
2.2.1 World Measles Attenuated Live Vaccine Consumption by Region (2018-2023)
2.2.2 World Measles Attenuated Live Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Measles Attenuated Live Vaccine Consumption (2018-2029)
2.4 China Measles Attenuated Live Vaccine Consumption (2018-2029)
2.5 Europe Measles Attenuated Live Vaccine Consumption (2018-2029)
2.6 Japan Measles Attenuated Live Vaccine Consumption (2018-2029)
2.7 South Korea Measles Attenuated Live Vaccine Consumption (2018-2029)
2.8 ASEAN Measles Attenuated Live Vaccine Consumption (2018-2029)
2.9 India Measles Attenuated Live Vaccine Consumption (2018-2029)
3 WORLD MEASLES ATTENUATED LIVE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Measles Attenuated Live Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Measles Attenuated Live Vaccine Production by Manufacturer (2018-2023)
3.3 World Measles Attenuated Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Measles Attenuated Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Measles Attenuated Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Measles Attenuated Live Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Measles Attenuated Live Vaccine in 2022
3.6 Measles Attenuated Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Measles Attenuated Live Vaccine Market: Region Footprint
3.6.2 Measles Attenuated Live Vaccine Market: Company Product Type Footprint
3.6.3 Measles Attenuated Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Measles Attenuated Live Vaccine Production Value Comparison
4.1.1 United States VS China: Measles Attenuated Live Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Measles Attenuated Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Measles Attenuated Live Vaccine Production Comparison
4.2.1 United States VS China: Measles Attenuated Live Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Measles Attenuated Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Measles Attenuated Live Vaccine Consumption Comparison
4.3.1 United States VS China: Measles Attenuated Live Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Measles Attenuated Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Measles Attenuated Live Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Measles Attenuated Live Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023)
4.5 China Based Measles Attenuated Live Vaccine Manufacturers and Market Share
4.5.1 China Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Measles Attenuated Live Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023)
4.6 Rest of World Based Measles Attenuated Live Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Measles Attenuated Live Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Powder
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Measles Attenuated Live Vaccine Production by Type (2018-2029)
5.3.2 World Measles Attenuated Live Vaccine Production Value by Type (2018-2029)
5.3.3 World Measles Attenuated Live Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Measles Attenuated Live Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Measles Attenuated Live Vaccine Production by Application (2018-2029)
6.3.2 World Measles Attenuated Live Vaccine Production Value by Application (2018-2029)
6.3.3 World Measles Attenuated Live Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Measles Attenuated Live Vaccine Product and Services
7.1.4 Merck Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Measles Attenuated Live Vaccine Product and Services
7.2.4 Pfizer Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Serum Institute of India
7.3.1 Serum Institute of India Details
7.3.2 Serum Institute of India Major Business
7.3.3 Serum Institute of India Measles Attenuated Live Vaccine Product and Services
7.3.4 Serum Institute of India Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Serum Institute of India Recent Developments/Updates
7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK Measles Attenuated Live Vaccine Product and Services
7.4.4 GSK Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Sanofi-Pasteur
7.5.1 Sanofi-Pasteur Details
7.5.2 Sanofi-Pasteur Major Business
7.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Product and Services
7.5.4 Sanofi-Pasteur Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi-Pasteur Recent Developments/Updates
7.5.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Measles Attenuated Live Vaccine Product and Services
7.6.4 Novartis Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Details
7.7.2 Bavarian Nordic Major Business
7.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Product and Services
7.7.4 Bavarian Nordic Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bavarian Nordic Recent Developments/Updates
7.7.6 Bavarian Nordic Competitive Strengths & Weaknesses
7.8 Medimmune
7.8.1 Medimmune Details
7.8.2 Medimmune Major Business
7.8.3 Medimmune Measles Attenuated Live Vaccine Product and Services
7.8.4 Medimmune Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Medimmune Recent Developments/Updates
7.8.6 Medimmune Competitive Strengths & Weaknesses
7.9 Changchun Keygen Biological Products
7.9.1 Changchun Keygen Biological Products Details
7.9.2 Changchun Keygen Biological Products Major Business
7.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product and Services
7.9.4 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Changchun Keygen Biological Products Recent Developments/Updates
7.9.6 Changchun Keygen Biological Products Competitive Strengths & Weaknesses
7.10 Shanghai Institute of Biological Products
7.10.1 Shanghai Institute of Biological Products Details
7.10.2 Shanghai Institute of Biological Products Major Business
7.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
7.10.4 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shanghai Institute of Biological Products Recent Developments/Updates
7.10.6 Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
7.11 Wuhan Institute of Biological Products
7.11.1 Wuhan Institute of Biological Products Details
7.11.2 Wuhan Institute of Biological Products Major Business
7.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
7.11.4 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.11.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.12 Lanzhou Institute of Biological Products
7.12.1 Lanzhou Institute of Biological Products Details
7.12.2 Lanzhou Institute of Biological Products Major Business
7.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
7.12.4 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.12.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Measles Attenuated Live Vaccine Industry Chain
8.2 Measles Attenuated Live Vaccine Upstream Analysis
8.2.1 Measles Attenuated Live Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Measles Attenuated Live Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Measles Attenuated Live Vaccine Production Mode
8.6 Measles Attenuated Live Vaccine Procurement Model
8.7 Measles Attenuated Live Vaccine Industry Sales Model and Sales Channels
8.7.1 Measles Attenuated Live Vaccine Sales Model
8.7.2 Measles Attenuated Live Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Measles Attenuated Live Vaccine Introduction
1.2 World Measles Attenuated Live Vaccine Supply & Forecast
1.2.1 World Measles Attenuated Live Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Measles Attenuated Live Vaccine Production (2018-2029)
1.2.3 World Measles Attenuated Live Vaccine Pricing Trends (2018-2029)
1.3 World Measles Attenuated Live Vaccine Production by Region (Based on Production Site)
1.3.1 World Measles Attenuated Live Vaccine Production Value by Region (2018-2029)
1.3.2 World Measles Attenuated Live Vaccine Production by Region (2018-2029)
1.3.3 World Measles Attenuated Live Vaccine Average Price by Region (2018-2029)
1.3.4 North America Measles Attenuated Live Vaccine Production (2018-2029)
1.3.5 Europe Measles Attenuated Live Vaccine Production (2018-2029)
1.3.6 China Measles Attenuated Live Vaccine Production (2018-2029)
1.3.7 Japan Measles Attenuated Live Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Measles Attenuated Live Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Measles Attenuated Live Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Measles Attenuated Live Vaccine Demand (2018-2029)
2.2 World Measles Attenuated Live Vaccine Consumption by Region
2.2.1 World Measles Attenuated Live Vaccine Consumption by Region (2018-2023)
2.2.2 World Measles Attenuated Live Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Measles Attenuated Live Vaccine Consumption (2018-2029)
2.4 China Measles Attenuated Live Vaccine Consumption (2018-2029)
2.5 Europe Measles Attenuated Live Vaccine Consumption (2018-2029)
2.6 Japan Measles Attenuated Live Vaccine Consumption (2018-2029)
2.7 South Korea Measles Attenuated Live Vaccine Consumption (2018-2029)
2.8 ASEAN Measles Attenuated Live Vaccine Consumption (2018-2029)
2.9 India Measles Attenuated Live Vaccine Consumption (2018-2029)
3 WORLD MEASLES ATTENUATED LIVE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Measles Attenuated Live Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Measles Attenuated Live Vaccine Production by Manufacturer (2018-2023)
3.3 World Measles Attenuated Live Vaccine Average Price by Manufacturer (2018-2023)
3.4 Measles Attenuated Live Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Measles Attenuated Live Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Measles Attenuated Live Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Measles Attenuated Live Vaccine in 2022
3.6 Measles Attenuated Live Vaccine Market: Overall Company Footprint Analysis
3.6.1 Measles Attenuated Live Vaccine Market: Region Footprint
3.6.2 Measles Attenuated Live Vaccine Market: Company Product Type Footprint
3.6.3 Measles Attenuated Live Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Measles Attenuated Live Vaccine Production Value Comparison
4.1.1 United States VS China: Measles Attenuated Live Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Measles Attenuated Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Measles Attenuated Live Vaccine Production Comparison
4.2.1 United States VS China: Measles Attenuated Live Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Measles Attenuated Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Measles Attenuated Live Vaccine Consumption Comparison
4.3.1 United States VS China: Measles Attenuated Live Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Measles Attenuated Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Measles Attenuated Live Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Measles Attenuated Live Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023)
4.5 China Based Measles Attenuated Live Vaccine Manufacturers and Market Share
4.5.1 China Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Measles Attenuated Live Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023)
4.6 Rest of World Based Measles Attenuated Live Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Measles Attenuated Live Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Powder
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Measles Attenuated Live Vaccine Production by Type (2018-2029)
5.3.2 World Measles Attenuated Live Vaccine Production Value by Type (2018-2029)
5.3.3 World Measles Attenuated Live Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Measles Attenuated Live Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Measles Attenuated Live Vaccine Production by Application (2018-2029)
6.3.2 World Measles Attenuated Live Vaccine Production Value by Application (2018-2029)
6.3.3 World Measles Attenuated Live Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Measles Attenuated Live Vaccine Product and Services
7.1.4 Merck Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Measles Attenuated Live Vaccine Product and Services
7.2.4 Pfizer Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Serum Institute of India
7.3.1 Serum Institute of India Details
7.3.2 Serum Institute of India Major Business
7.3.3 Serum Institute of India Measles Attenuated Live Vaccine Product and Services
7.3.4 Serum Institute of India Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Serum Institute of India Recent Developments/Updates
7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK Measles Attenuated Live Vaccine Product and Services
7.4.4 GSK Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Sanofi-Pasteur
7.5.1 Sanofi-Pasteur Details
7.5.2 Sanofi-Pasteur Major Business
7.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Product and Services
7.5.4 Sanofi-Pasteur Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi-Pasteur Recent Developments/Updates
7.5.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Measles Attenuated Live Vaccine Product and Services
7.6.4 Novartis Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Details
7.7.2 Bavarian Nordic Major Business
7.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Product and Services
7.7.4 Bavarian Nordic Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bavarian Nordic Recent Developments/Updates
7.7.6 Bavarian Nordic Competitive Strengths & Weaknesses
7.8 Medimmune
7.8.1 Medimmune Details
7.8.2 Medimmune Major Business
7.8.3 Medimmune Measles Attenuated Live Vaccine Product and Services
7.8.4 Medimmune Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Medimmune Recent Developments/Updates
7.8.6 Medimmune Competitive Strengths & Weaknesses
7.9 Changchun Keygen Biological Products
7.9.1 Changchun Keygen Biological Products Details
7.9.2 Changchun Keygen Biological Products Major Business
7.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product and Services
7.9.4 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Changchun Keygen Biological Products Recent Developments/Updates
7.9.6 Changchun Keygen Biological Products Competitive Strengths & Weaknesses
7.10 Shanghai Institute of Biological Products
7.10.1 Shanghai Institute of Biological Products Details
7.10.2 Shanghai Institute of Biological Products Major Business
7.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
7.10.4 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shanghai Institute of Biological Products Recent Developments/Updates
7.10.6 Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
7.11 Wuhan Institute of Biological Products
7.11.1 Wuhan Institute of Biological Products Details
7.11.2 Wuhan Institute of Biological Products Major Business
7.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
7.11.4 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.11.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.12 Lanzhou Institute of Biological Products
7.12.1 Lanzhou Institute of Biological Products Details
7.12.2 Lanzhou Institute of Biological Products Major Business
7.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
7.12.4 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.12.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Measles Attenuated Live Vaccine Industry Chain
8.2 Measles Attenuated Live Vaccine Upstream Analysis
8.2.1 Measles Attenuated Live Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Measles Attenuated Live Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Measles Attenuated Live Vaccine Production Mode
8.6 Measles Attenuated Live Vaccine Procurement Model
8.7 Measles Attenuated Live Vaccine Industry Sales Model and Sales Channels
8.7.1 Measles Attenuated Live Vaccine Sales Model
8.7.2 Measles Attenuated Live Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Measles Attenuated Live Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Measles Attenuated Live Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Measles Attenuated Live Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Measles Attenuated Live Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Measles Attenuated Live Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Measles Attenuated Live Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Measles Attenuated Live Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Measles Attenuated Live Vaccine Production Market Share by Region (2018-2023)
Table 9. World Measles Attenuated Live Vaccine Production Market Share by Region (2024-2029)
Table 10. World Measles Attenuated Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Measles Attenuated Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Measles Attenuated Live Vaccine Major Market Trends
Table 13. World Measles Attenuated Live Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Measles Attenuated Live Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Measles Attenuated Live Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Measles Attenuated Live Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Measles Attenuated Live Vaccine Producers in 2022
Table 18. World Measles Attenuated Live Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Measles Attenuated Live Vaccine Producers in 2022
Table 20. World Measles Attenuated Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Measles Attenuated Live Vaccine Company Evaluation Quadrant
Table 22. World Measles Attenuated Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Measles Attenuated Live Vaccine Production Site of Key Manufacturer
Table 24. Measles Attenuated Live Vaccine Market: Company Product Type Footprint
Table 25. Measles Attenuated Live Vaccine Market: Company Product Application Footprint
Table 26. Measles Attenuated Live Vaccine Competitive Factors
Table 27. Measles Attenuated Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Measles Attenuated Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Measles Attenuated Live Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Measles Attenuated Live Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Measles Attenuated Live Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Measles Attenuated Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Measles Attenuated Live Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Measles Attenuated Live Vaccine Production Market Share (2018-2023)
Table 37. China Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Measles Attenuated Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Measles Attenuated Live Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Measles Attenuated Live Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Market Share (2018-2023)
Table 47. World Measles Attenuated Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Measles Attenuated Live Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Measles Attenuated Live Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Measles Attenuated Live Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Measles Attenuated Live Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Measles Attenuated Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Measles Attenuated Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Measles Attenuated Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Measles Attenuated Live Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Measles Attenuated Live Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Measles Attenuated Live Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Measles Attenuated Live Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Measles Attenuated Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Measles Attenuated Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Measles Attenuated Live Vaccine Product and Services
Table 64. Merck Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Measles Attenuated Live Vaccine Product and Services
Table 70. Pfizer Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Major Business
Table 75. Serum Institute of India Measles Attenuated Live Vaccine Product and Services
Table 76. Serum Institute of India Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. Serum Institute of India Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK Measles Attenuated Live Vaccine Product and Services
Table 82. GSK Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi-Pasteur Major Business
Table 87. Sanofi-Pasteur Measles Attenuated Live Vaccine Product and Services
Table 88. Sanofi-Pasteur Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi-Pasteur Recent Developments/Updates
Table 90. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 91. Novartis Basic Information, Manufacturing Base and Competitors
Table 92. Novartis Major Business
Table 93. Novartis Measles Attenuated Live Vaccine Product and Services
Table 94. Novartis Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Novartis Recent Developments/Updates
Table 96. Novartis Competitive Strengths & Weaknesses
Table 97. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 98. Bavarian Nordic Major Business
Table 99. Bavarian Nordic Measles Attenuated Live Vaccine Product and Services
Table 100. Bavarian Nordic Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bavarian Nordic Recent Developments/Updates
Table 102. Bavarian Nordic Competitive Strengths & Weaknesses
Table 103. Medimmune Basic Information, Manufacturing Base and Competitors
Table 104. Medimmune Major Business
Table 105. Medimmune Measles Attenuated Live Vaccine Product and Services
Table 106. Medimmune Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Medimmune Recent Developments/Updates
Table 108. Medimmune Competitive Strengths & Weaknesses
Table 109. Changchun Keygen Biological Products Basic Information, Manufacturing Base and Competitors
Table 110. Changchun Keygen Biological Products Major Business
Table 111. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product and Services
Table 112. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Changchun Keygen Biological Products Recent Developments/Updates
Table 114. Changchun Keygen Biological Products Competitive Strengths & Weaknesses
Table 115. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Institute of Biological Products Major Business
Table 117. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 118. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shanghai Institute of Biological Products Recent Developments/Updates
Table 120. Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
Table 121. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 122. Wuhan Institute of Biological Products Major Business
Table 123. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 124. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Wuhan Institute of Biological Products Recent Developments/Updates
Table 126. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 127. Lanzhou Institute of Biological Products Major Business
Table 128. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 129. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Measles Attenuated Live Vaccine Upstream (Raw Materials)
Table 131. Measles Attenuated Live Vaccine Typical Customers
Table 132. Measles Attenuated Live Vaccine Typical Distributors
Table 1. World Measles Attenuated Live Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Measles Attenuated Live Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Measles Attenuated Live Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Measles Attenuated Live Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Measles Attenuated Live Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Measles Attenuated Live Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Measles Attenuated Live Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Measles Attenuated Live Vaccine Production Market Share by Region (2018-2023)
Table 9. World Measles Attenuated Live Vaccine Production Market Share by Region (2024-2029)
Table 10. World Measles Attenuated Live Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Measles Attenuated Live Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Measles Attenuated Live Vaccine Major Market Trends
Table 13. World Measles Attenuated Live Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Measles Attenuated Live Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Measles Attenuated Live Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Measles Attenuated Live Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Measles Attenuated Live Vaccine Producers in 2022
Table 18. World Measles Attenuated Live Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Measles Attenuated Live Vaccine Producers in 2022
Table 20. World Measles Attenuated Live Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Measles Attenuated Live Vaccine Company Evaluation Quadrant
Table 22. World Measles Attenuated Live Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Measles Attenuated Live Vaccine Production Site of Key Manufacturer
Table 24. Measles Attenuated Live Vaccine Market: Company Product Type Footprint
Table 25. Measles Attenuated Live Vaccine Market: Company Product Application Footprint
Table 26. Measles Attenuated Live Vaccine Competitive Factors
Table 27. Measles Attenuated Live Vaccine New Entrant and Capacity Expansion Plans
Table 28. Measles Attenuated Live Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Measles Attenuated Live Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Measles Attenuated Live Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Measles Attenuated Live Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Measles Attenuated Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Measles Attenuated Live Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Measles Attenuated Live Vaccine Production Market Share (2018-2023)
Table 37. China Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Measles Attenuated Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Measles Attenuated Live Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Measles Attenuated Live Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Measles Attenuated Live Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Market Share (2018-2023)
Table 47. World Measles Attenuated Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Measles Attenuated Live Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Measles Attenuated Live Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Measles Attenuated Live Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Measles Attenuated Live Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Measles Attenuated Live Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Measles Attenuated Live Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Measles Attenuated Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Measles Attenuated Live Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Measles Attenuated Live Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Measles Attenuated Live Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Measles Attenuated Live Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Measles Attenuated Live Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Measles Attenuated Live Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Measles Attenuated Live Vaccine Product and Services
Table 64. Merck Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Measles Attenuated Live Vaccine Product and Services
Table 70. Pfizer Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Major Business
Table 75. Serum Institute of India Measles Attenuated Live Vaccine Product and Services
Table 76. Serum Institute of India Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. Serum Institute of India Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK Measles Attenuated Live Vaccine Product and Services
Table 82. GSK Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi-Pasteur Major Business
Table 87. Sanofi-Pasteur Measles Attenuated Live Vaccine Product and Services
Table 88. Sanofi-Pasteur Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi-Pasteur Recent Developments/Updates
Table 90. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 91. Novartis Basic Information, Manufacturing Base and Competitors
Table 92. Novartis Major Business
Table 93. Novartis Measles Attenuated Live Vaccine Product and Services
Table 94. Novartis Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Novartis Recent Developments/Updates
Table 96. Novartis Competitive Strengths & Weaknesses
Table 97. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 98. Bavarian Nordic Major Business
Table 99. Bavarian Nordic Measles Attenuated Live Vaccine Product and Services
Table 100. Bavarian Nordic Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bavarian Nordic Recent Developments/Updates
Table 102. Bavarian Nordic Competitive Strengths & Weaknesses
Table 103. Medimmune Basic Information, Manufacturing Base and Competitors
Table 104. Medimmune Major Business
Table 105. Medimmune Measles Attenuated Live Vaccine Product and Services
Table 106. Medimmune Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Medimmune Recent Developments/Updates
Table 108. Medimmune Competitive Strengths & Weaknesses
Table 109. Changchun Keygen Biological Products Basic Information, Manufacturing Base and Competitors
Table 110. Changchun Keygen Biological Products Major Business
Table 111. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product and Services
Table 112. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Changchun Keygen Biological Products Recent Developments/Updates
Table 114. Changchun Keygen Biological Products Competitive Strengths & Weaknesses
Table 115. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Institute of Biological Products Major Business
Table 117. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 118. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shanghai Institute of Biological Products Recent Developments/Updates
Table 120. Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
Table 121. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 122. Wuhan Institute of Biological Products Major Business
Table 123. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 124. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Wuhan Institute of Biological Products Recent Developments/Updates
Table 126. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 127. Lanzhou Institute of Biological Products Major Business
Table 128. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product and Services
Table 129. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Measles Attenuated Live Vaccine Upstream (Raw Materials)
Table 131. Measles Attenuated Live Vaccine Typical Customers
Table 132. Measles Attenuated Live Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Measles Attenuated Live Vaccine Picture
Figure 2. World Measles Attenuated Live Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Measles Attenuated Live Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 5. World Measles Attenuated Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Measles Attenuated Live Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Measles Attenuated Live Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 10. China Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 12. Measles Attenuated Live Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Measles Attenuated Live Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Measles Attenuated Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Measles Attenuated Live Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Measles Attenuated Live Vaccine Markets in 2022
Figure 26. United States VS China: Measles Attenuated Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Measles Attenuated Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Measles Attenuated Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Measles Attenuated Live Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Measles Attenuated Live Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Market Share 2022
Figure 32. World Measles Attenuated Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Measles Attenuated Live Vaccine Production Value Market Share by Type in 2022
Figure 34. Powder
Figure 35. Liquid
Figure 36. World Measles Attenuated Live Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Measles Attenuated Live Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Measles Attenuated Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Measles Attenuated Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Measles Attenuated Live Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Measles Attenuated Live Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Measles Attenuated Live Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Measles Attenuated Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Measles Attenuated Live Vaccine Industry Chain
Figure 47. Measles Attenuated Live Vaccine Procurement Model
Figure 48. Measles Attenuated Live Vaccine Sales Model
Figure 49. Measles Attenuated Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Measles Attenuated Live Vaccine Picture
Figure 2. World Measles Attenuated Live Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Measles Attenuated Live Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 5. World Measles Attenuated Live Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Measles Attenuated Live Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Measles Attenuated Live Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 10. China Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Measles Attenuated Live Vaccine Production (2018-2029) & (K Units)
Figure 12. Measles Attenuated Live Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Measles Attenuated Live Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Measles Attenuated Live Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Measles Attenuated Live Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Measles Attenuated Live Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Measles Attenuated Live Vaccine Markets in 2022
Figure 26. United States VS China: Measles Attenuated Live Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Measles Attenuated Live Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Measles Attenuated Live Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Measles Attenuated Live Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Measles Attenuated Live Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Measles Attenuated Live Vaccine Production Market Share 2022
Figure 32. World Measles Attenuated Live Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Measles Attenuated Live Vaccine Production Value Market Share by Type in 2022
Figure 34. Powder
Figure 35. Liquid
Figure 36. World Measles Attenuated Live Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Measles Attenuated Live Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Measles Attenuated Live Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Measles Attenuated Live Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Measles Attenuated Live Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Measles Attenuated Live Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Measles Attenuated Live Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Measles Attenuated Live Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Measles Attenuated Live Vaccine Industry Chain
Figure 47. Measles Attenuated Live Vaccine Procurement Model
Figure 48. Measles Attenuated Live Vaccine Sales Model
Figure 49. Measles Attenuated Live Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
